Sage Growth Partners (SGP), a Baltimore-based healthcare research, strategy, and marketing firm, is thrilled to announce the addition of Jennifer Walsh to their team. Walsh joins as the new Senior Vice President of Sales, bringing with her over 20 years of experience in business development, market research, sales, and business analytics.
Prior to joining SGP, Walsh held a director position at Nixon Peabody, LLP, a global law firm, where she focused on strategic growth in the healthcare and life sciences industries. She has also served as the director of client engagement at CMK Select, identifying and qualifying new business opportunities in various areas. Additionally, she has held director level roles at IMS Health, EKR Therapeutics, and Strativa Pharmaceuticals, gaining extensive experience in market research and business analytics.
According to Dan D’Orazio, Sage Growth Partners CEO, Walsh’s wealth of knowledge about the healthcare industry is a significant asset to the firm. Her ability to develop strong relationships with industry decision makers will contribute to the continued growth of their client base. Walsh expressed her excitement about joining the team, citing Sage’s reputation for exceptional client service and innovative thinking.
Walsh earned her bachelor’s degree in marketing and communication from the SUNY Fashion Institute of Technology in New York. She is also a former member of Intellus Worldwide, where she served on committees focused on healthcare insights and analytics.
Sage Growth Partners, founded in 2005, is a healthcare advisory firm specializing in market research, strategy, and communications. Their expertise helps healthcare organizations thrive in a rapidly changing marketplace. They serve a wide range of clients in the healthcare industry, including GE Healthcare, Medecision, and Philips Healthcare.
Sources:
– Sage Growth Partners
– PR Newswire
